Last reviewed · How we verify
NCT04637178: IDperform
Predicting the Efficacy of Resistance Exercise Training for Improving Endurance Performance
NA trial testing Resistance training in Elite Cyclists in 25 participants. Completed in 26 February 2021.
26 February 2021
Quick facts
| Lead sponsor | Inland Norway University of Applied Sciences |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 25 |
| Start date | 16 November 2020 |
| Primary completion | 26 February 2021 |
| Estimated completion | 26 February 2021 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Resistance training
- Endurance training (habitual)
Conditions studied
- Elite Cyclists — all drugs for Elite Cyclists →
Sponsor
Inland Norway University of Applied Sciences
Who can join
Adults 18 to 45, any sex, with Elite Cyclists. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall objective of the study is to identify molecular determinants of the efficacy of resistance training for improving endruance performance in elite cyclists
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04637178
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Resistance training
Trials testing the same drug.
- NCT07166198 — Mitigating Neural Hypoexcitability and Weakness During Disuse in Women · NA · not yet recruiting
- NCT07411625 — Preoperative Rehabilitation for Patient With an ACL Injury · NA · recruiting
- NCT07484776 — Metabolic Flexibility in Patients With Early Triple-negative Breast Cancer · NA · active not recruiting
- NCT07341698 — Prehabilitation for Patients Diagnosed With Blood Cancer and Treated With Al-logeneic Hematopoietic Stem Cell Transplant · NA · recruiting
- NCT07058818 — Tailored Resistance Training After Adverse Pregnancy Outcomes · NA · completed
Other Inland Norway University of Applied Sciences trials
Trials by the same sponsor.
- NCT07159815 — REACT - Resistance Exercise After Cancer Treatment · NA · recruiting
- NCT06611566 — VR-guided Exercise and Mindfulness Program for People with Chronic Pain · NA · completed
- NCT04611646 — Effects of Heat-suit Training on Biological and Performance Characteristics in Elite Cyclists · NA · completed
- NCT04545190 — RibOSE - Glucose and Resistance Exercise Training · NA · completed
- NCT04196725 — Effect of Lifestyle Intervention vs Physical Therapy Treatment in Patients With Secondary Lymphedema After Cancer · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04637178 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Inland Norway University of Applied Sciences
- Last refreshed: 1 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04637178.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing